[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @Reuters_Health Reuters Health Reuters Health posts on X about novartis, breast cancer, $8750t, cbc the most. They currently have XXXXXXX followers and XXX posts still getting attention that total XXXXX engagements in the last XX hours. ### Engagements: XXXXX [#](/creator/twitter::25562183/interactions)  - X Week XXXXXX +51% - X Month XXXXXX +7.30% - X Months XXXXXXX -XX% - X Year XXXXXXX -XX% ### Mentions: XX [#](/creator/twitter::25562183/posts_active)  - X Week XX +77% - X Month XX -XX% - X Months XXX -XX% - X Year XXXXX -XX% ### Followers: XXXXXXX [#](/creator/twitter::25562183/followers)  - X Week XXXXXXX -XXXX% - X Month XXXXXXX -XXXX% - X Months XXXXXXX -XXXX% - X Year XXXXXXX -XXXX% ### CreatorRank: XXXXXXX [#](/creator/twitter::25562183/influencer_rank)  ### Social Influence [#](/creator/twitter::25562183/influence) --- **Social category influence** [stocks](/list/stocks) XXX% [finance](/list/finance) XXX% [countries](/list/countries) XXXX% **Social topic influence** [novartis](/topic/novartis) #6, [breast cancer](/topic/breast-cancer) #386, [$8750t](/topic/$8750t) #11, [cbc](/topic/cbc) 0.7%, [swiss](/topic/swiss) #82, [german](/topic/german) 0.47%, [state of](/topic/state-of) 0.23%, [france](/topic/france) 0.23%, [surge](/topic/surge) 0.23%, [inflation](/topic/inflation) XXXX% **Top accounts mentioned or mentioned by** [@matt_gustaf](/creator/undefined) [@hubanc51574](/creator/undefined) [@pembesina56069](/creator/undefined) [@efilinonu18739](/creator/undefined) **Top assets mentioned** [Novartis AG (NVS)](/topic/novartis) ### Top Social Posts [#](/creator/twitter::25562183/posts) --- Top posts by engagements in the last XX hours "Indian drugmaker Sun Pharmaceutical Industries said on Tuesday the U.S. Food and Drug Administration had determined that its Halol plant in the western state of Gujarat was not compliant with the regulator's manufacturing rules" [X Link](https://x.com/Reuters_Health/status/1965445278770573756) [@Reuters_Health](/creator/x/Reuters_Health) 2025-09-09T16:00Z 253.4K followers, XXX engagements "AstraZeneca and Daiichi Sankyo's precision drug Datroway improved survival prospects in patients with an advanced form of breast cancer in a late-stage trial the drugmakers said on Monday paving the way for broader approvals" [X Link](https://x.com/Reuters_Health/status/1975222149238382856) [@Reuters_Health](/creator/x/Reuters_Health) 2025-10-06T15:30Z 253.5K followers, XXX engagements "CBC Group Asia's largest healthcare-focused asset manager has raised $XXX million for its second R-Bridge Healthcare Fund making it the region's biggest healthcare private credit fund the company said on Wednesday" [X Link](https://x.com/Reuters_Health/status/1978268372983767212) [@Reuters_Health](/creator/x/Reuters_Health) 2025-10-15T01:15Z 253.5K followers, XXX engagements "CBC Group Asia's largest healthcare-focused asset manager has raised $XXX million for its second R-Bridge Healthcare Fund making it the region's biggest healthcare private credit fund the company said on Wednesday" [X Link](https://x.com/Reuters_Health/status/1978332585592758287) [@Reuters_Health](/creator/x/Reuters_Health) 2025-10-15T05:30Z 253.5K followers, XXX engagements "CBC Group Asia's largest healthcare-focused asset manager has raised $XXX million for its second R-Bridge Healthcare Fund making it the region's biggest healthcare private credit fund the company said on Wednesday" [X Link](https://x.com/Reuters_Health/status/1978396740907585806) [@Reuters_Health](/creator/x/Reuters_Health) 2025-10-15T09:45Z 253.5K followers, XXX engagements "German pharmaceuticals and technology company Merck KGaA slightly improved its mid-term guidance for its healthcare business ahead of its capital markets day on Thursday" [X Link](https://x.com/Reuters_Health/status/1978691174996045944) [@Reuters_Health](/creator/x/Reuters_Health) 2025-10-16T05:15Z 253.5K followers, XXX engagements "Novartis said on Thursday its Fabhalta drug was shown to meaningfully slow the progression of a rare type of kidney disease under final results of a late-stage trial" [X Link](https://x.com/Reuters_Health/status/1978698719508804022) [@Reuters_Health](/creator/x/Reuters_Health) 2025-10-16T05:45Z 253.5K followers, XXX engagements "German pharmaceuticals and technology company Merck KGaA slightly improved its mid-term guidance for its healthcare business ahead of its capital markets day on Thursday" [X Link](https://x.com/Reuters_Health/status/1978755384643842357) [@Reuters_Health](/creator/x/Reuters_Health) 2025-10-16T09:30Z 253.5K followers, XXX engagements "Novartis said on Thursday its Fabhalta drug was shown to meaningfully slow the progression of a rare type of kidney disease under final results of a late-stage trial" [X Link](https://x.com/Reuters_Health/status/1978763042285297991) [@Reuters_Health](/creator/x/Reuters_Health) 2025-10-16T10:00Z 253.5K followers, XXX engagements "Novartis said on Thursday its Fabhalta drug was shown to meaningfully slow the progression of a rare type of kidney disease under final results of a late-stage trial" [X Link](https://x.com/Reuters_Health/status/1978827112606753065) [@Reuters_Health](/creator/x/Reuters_Health) 2025-10-16T14:15Z 253.5K followers, XXX engagements "France is struggling to contain a surge in cases of lumpy skin disease in cattle with a new outbreak found near the Spanish border as the highly contagious virus sweeps across Western Europe for the first time" [X Link](https://x.com/Reuters_Health/status/1978974548419547397) [@Reuters_Health](/creator/x/Reuters_Health) 2025-10-17T00:01Z 253.5K followers, XXX engagements "From Breakingviews - Inflation targets are no match for fiscal neglect" [X Link](https://x.com/Reuters_Health/status/1979121480827810118) [@Reuters_Health](/creator/x/Reuters_Health) 2025-10-17T09:45Z 253.5K followers, XXX engagements "From Breakingviews - How Credit Suisse's CoCos could rise from the dead" [X Link](https://x.com/Reuters_Health/status/1979151681876086833) [@Reuters_Health](/creator/x/Reuters_Health) 2025-10-17T11:45Z 253.5K followers, XXX engagements "From Breakingviews - How Credit Suisse's CoCos could rise from the dead" [X Link](https://x.com/Reuters_Health/status/1979215982867398901) [@Reuters_Health](/creator/x/Reuters_Health) 2025-10-17T16:00Z 253.5K followers, XXX engagements "AstraZeneca and Daiichi Sankyo's precision drug Datroway improved survival prospects in patients with an advanced form of breast cancer in a late-stage trial the drugmakers said on Monday paving the way for broader approvals" [X Link](https://x.com/Reuters_Health/status/1975157895558730130) [@Reuters_Health](/creator/x/Reuters_Health) 2025-10-06T11:15Z 253.5K followers, XXX engagements "AstraZeneca and Daiichi Sankyo's drug Enhertu has shown strong results in two pivotal studies in the early stage of a certain type of breast cancer according to data announced on Saturday" [X Link](https://x.com/Reuters_Health/status/1979559366362620254) [@Reuters_Health](/creator/x/Reuters_Health) 2025-10-18T14:45Z 253.5K followers, XXX engagements "AstraZeneca and Daiichi Sankyo's new breast cancer drug helped significantly extend survival in some patients in a late-stage trial marking a potential breakthrough in one of the hardest-to-treat forms of the disease" [X Link](https://x.com/Reuters_Health/status/1979800960340824217) [@Reuters_Health](/creator/x/Reuters_Health) 2025-10-19T06:45Z 253.5K followers, XXX engagements "Namibia's ministry of health and social services on Sunday declared an outbreak of mpox in the city of Swakopmund" [X Link](https://x.com/Reuters_Health/status/1979902928862253222) [@Reuters_Health](/creator/x/Reuters_Health) 2025-10-19T13:30Z 253.5K followers, XXX engagements "Datroway's success could position it to compete more directly with Gilead's Trodelvy" [X Link](https://x.com/Reuters_Health/status/1979906657392918605) [@Reuters_Health](/creator/x/Reuters_Health) 2025-10-19T13:45Z 253.5K followers, XXX engagements "Swiss drugmaker Novartis said on Sunday its targeted radiotherapy treatment Pluvicto reduced the risk of progression or death in patients with prostate cancer by 28%" [X Link](https://x.com/Reuters_Health/status/1979929303996342570) [@Reuters_Health](/creator/x/Reuters_Health) 2025-10-19T15:15Z 253.5K followers, XXX engagements "Namibia's ministry of health and social services on Sunday declared an outbreak of mpox in the city of Swakopmund" [X Link](https://x.com/Reuters_Health/status/1979967047036469611) [@Reuters_Health](/creator/x/Reuters_Health) 2025-10-19T17:45Z 253.5K followers, XXX engagements "Datroway's success could position it to compete more directly with Gilead's Trodelvy" [X Link](https://x.com/Reuters_Health/status/1979971017528263079) [@Reuters_Health](/creator/x/Reuters_Health) 2025-10-19T18:00Z 253.5K followers, XXX engagements "Swiss drugmaker Novartis said on Sunday its targeted radiotherapy treatment Pluvicto reduced the risk of progression or death in patients with prostate cancer by 28%" [X Link](https://x.com/Reuters_Health/status/1979993528093606343) [@Reuters_Health](/creator/x/Reuters_Health) 2025-10-19T19:30Z 253.5K followers, XXX engagements "Namibia's ministry of health and social services on Sunday declared an outbreak of mpox in the city of Swakopmund" [X Link](https://x.com/Reuters_Health/status/1980031406739702090) [@Reuters_Health](/creator/x/Reuters_Health) 2025-10-19T22:00Z 253.5K followers, XXX engagements "Swiss drugmaker Novartis said on Sunday its targeted radiotherapy treatment Pluvicto reduced the risk of progression or death in patients with prostate cancer by 28%" [X Link](https://x.com/Reuters_Health/status/1980057651183599831) [@Reuters_Health](/creator/x/Reuters_Health) 2025-10-19T23:45Z 253.5K followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Reuters Health posts on X about novartis, breast cancer, $8750t, cbc the most. They currently have XXXXXXX followers and XXX posts still getting attention that total XXXXX engagements in the last XX hours.
Social category influence stocks XXX% finance XXX% countries XXXX%
Social topic influence novartis #6, breast cancer #386, $8750t #11, cbc 0.7%, swiss #82, german 0.47%, state of 0.23%, france 0.23%, surge 0.23%, inflation XXXX%
Top accounts mentioned or mentioned by @matt_gustaf @hubanc51574 @pembesina56069 @efilinonu18739
Top assets mentioned Novartis AG (NVS)
Top posts by engagements in the last XX hours
"Indian drugmaker Sun Pharmaceutical Industries said on Tuesday the U.S. Food and Drug Administration had determined that its Halol plant in the western state of Gujarat was not compliant with the regulator's manufacturing rules"
X Link @Reuters_Health 2025-09-09T16:00Z 253.4K followers, XXX engagements
"AstraZeneca and Daiichi Sankyo's precision drug Datroway improved survival prospects in patients with an advanced form of breast cancer in a late-stage trial the drugmakers said on Monday paving the way for broader approvals"
X Link @Reuters_Health 2025-10-06T15:30Z 253.5K followers, XXX engagements
"CBC Group Asia's largest healthcare-focused asset manager has raised $XXX million for its second R-Bridge Healthcare Fund making it the region's biggest healthcare private credit fund the company said on Wednesday"
X Link @Reuters_Health 2025-10-15T01:15Z 253.5K followers, XXX engagements
"CBC Group Asia's largest healthcare-focused asset manager has raised $XXX million for its second R-Bridge Healthcare Fund making it the region's biggest healthcare private credit fund the company said on Wednesday"
X Link @Reuters_Health 2025-10-15T05:30Z 253.5K followers, XXX engagements
"CBC Group Asia's largest healthcare-focused asset manager has raised $XXX million for its second R-Bridge Healthcare Fund making it the region's biggest healthcare private credit fund the company said on Wednesday"
X Link @Reuters_Health 2025-10-15T09:45Z 253.5K followers, XXX engagements
"German pharmaceuticals and technology company Merck KGaA slightly improved its mid-term guidance for its healthcare business ahead of its capital markets day on Thursday"
X Link @Reuters_Health 2025-10-16T05:15Z 253.5K followers, XXX engagements
"Novartis said on Thursday its Fabhalta drug was shown to meaningfully slow the progression of a rare type of kidney disease under final results of a late-stage trial"
X Link @Reuters_Health 2025-10-16T05:45Z 253.5K followers, XXX engagements
"German pharmaceuticals and technology company Merck KGaA slightly improved its mid-term guidance for its healthcare business ahead of its capital markets day on Thursday"
X Link @Reuters_Health 2025-10-16T09:30Z 253.5K followers, XXX engagements
"Novartis said on Thursday its Fabhalta drug was shown to meaningfully slow the progression of a rare type of kidney disease under final results of a late-stage trial"
X Link @Reuters_Health 2025-10-16T10:00Z 253.5K followers, XXX engagements
"Novartis said on Thursday its Fabhalta drug was shown to meaningfully slow the progression of a rare type of kidney disease under final results of a late-stage trial"
X Link @Reuters_Health 2025-10-16T14:15Z 253.5K followers, XXX engagements
"France is struggling to contain a surge in cases of lumpy skin disease in cattle with a new outbreak found near the Spanish border as the highly contagious virus sweeps across Western Europe for the first time"
X Link @Reuters_Health 2025-10-17T00:01Z 253.5K followers, XXX engagements
"From Breakingviews - Inflation targets are no match for fiscal neglect"
X Link @Reuters_Health 2025-10-17T09:45Z 253.5K followers, XXX engagements
"From Breakingviews - How Credit Suisse's CoCos could rise from the dead"
X Link @Reuters_Health 2025-10-17T11:45Z 253.5K followers, XXX engagements
"From Breakingviews - How Credit Suisse's CoCos could rise from the dead"
X Link @Reuters_Health 2025-10-17T16:00Z 253.5K followers, XXX engagements
"AstraZeneca and Daiichi Sankyo's precision drug Datroway improved survival prospects in patients with an advanced form of breast cancer in a late-stage trial the drugmakers said on Monday paving the way for broader approvals"
X Link @Reuters_Health 2025-10-06T11:15Z 253.5K followers, XXX engagements
"AstraZeneca and Daiichi Sankyo's drug Enhertu has shown strong results in two pivotal studies in the early stage of a certain type of breast cancer according to data announced on Saturday"
X Link @Reuters_Health 2025-10-18T14:45Z 253.5K followers, XXX engagements
"AstraZeneca and Daiichi Sankyo's new breast cancer drug helped significantly extend survival in some patients in a late-stage trial marking a potential breakthrough in one of the hardest-to-treat forms of the disease"
X Link @Reuters_Health 2025-10-19T06:45Z 253.5K followers, XXX engagements
"Namibia's ministry of health and social services on Sunday declared an outbreak of mpox in the city of Swakopmund"
X Link @Reuters_Health 2025-10-19T13:30Z 253.5K followers, XXX engagements
"Datroway's success could position it to compete more directly with Gilead's Trodelvy"
X Link @Reuters_Health 2025-10-19T13:45Z 253.5K followers, XXX engagements
"Swiss drugmaker Novartis said on Sunday its targeted radiotherapy treatment Pluvicto reduced the risk of progression or death in patients with prostate cancer by 28%"
X Link @Reuters_Health 2025-10-19T15:15Z 253.5K followers, XXX engagements
"Namibia's ministry of health and social services on Sunday declared an outbreak of mpox in the city of Swakopmund"
X Link @Reuters_Health 2025-10-19T17:45Z 253.5K followers, XXX engagements
"Datroway's success could position it to compete more directly with Gilead's Trodelvy"
X Link @Reuters_Health 2025-10-19T18:00Z 253.5K followers, XXX engagements
"Swiss drugmaker Novartis said on Sunday its targeted radiotherapy treatment Pluvicto reduced the risk of progression or death in patients with prostate cancer by 28%"
X Link @Reuters_Health 2025-10-19T19:30Z 253.5K followers, XXX engagements
"Namibia's ministry of health and social services on Sunday declared an outbreak of mpox in the city of Swakopmund"
X Link @Reuters_Health 2025-10-19T22:00Z 253.5K followers, XXX engagements
"Swiss drugmaker Novartis said on Sunday its targeted radiotherapy treatment Pluvicto reduced the risk of progression or death in patients with prostate cancer by 28%"
X Link @Reuters_Health 2025-10-19T23:45Z 253.5K followers, XXX engagements
/creator/twitter::Reuters_Health